Uncategorized

MARCH 16, 2022 Detection of Minimal Residual Disease Minimal residual disease (MRD) is defined as a very small number of cancer cells that remain in the body during or after treatment1. This may be locally at the site of surgery, distant at metastatic sites or at unknown micrometastatic deposits. The assessment of post-treatment minimal residual…

November 17, 2021 Current screening limitations Cancer is a leading cause of morbidity and mortality globally. Despite early diagnosis and treatment being one of the most effective methods to improve outcomes for cancer patients, early detection remains challenging. Screening methods are available for some tumour types, such as the smear test for cervical cancer and mammography for breast cancer1,2. However, these early…